Pregnancy Complication Clinical Trial
During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03626597 -
Community-based Provision of Urine Pregnancy Tests as Linkage to Reproductive Health Services
|
N/A | |
Recruiting |
NCT02372487 -
Sildenafil Citrate Therapy for Oligohydramnios
|
N/A | |
Completed |
NCT02362399 -
Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses
|
N/A | |
Completed |
NCT00901758 -
Intravenous (IV) Nitroglycerin for Versions in Multiparous Women
|
N/A | |
Recruiting |
NCT06113237 -
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
|
||
Completed |
NCT01762683 -
Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype
|
N/A |